VolitionRx shareholders approve authorized share increase to 325M; all director nominees elected

On June 18, 2025, VolitionRx Limited (the " Company ") held its annual meeting of stockholders (the " Annual Meeting "). At the Annual Meeting, the Company’s stockholders approved a Certificate of Second Amendment (the " Amendment ") of the Second Amended and Restated Certificate of Incorporation (the " Restated Certificate "), providing for an increase in authorized shares from one hundred seventy-five million (175,000,000) shares to three hundred twenty-five million (325,000,000) shares, consisting of three hundred twenty-five million (325,000,000) shares of common stock, par value $0.001 per share. The Amendment had previously been approved by the Board of Directors on April 2, 2025, subject to the approval of the Company’s Stockholders. The Amendment became effective upon its filing with the Secretary of State of the State of Delaware on June 18, 2025.